RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $349,000 | -97.6% | 100,000 | -75.0% | 0.05% | -97.2% |
| Q3 2022 | $14,808,000 | +94.9% | 400,000 | 0.0% | 1.82% | +57.5% |
| Q2 2022 | $7,596,000 | +470.3% | 400,000 | +576.6% | 1.15% | +330.2% |
| Q4 2021 | $1,332,000 | -49.2% | 59,122 | -40.9% | 0.27% | -50.7% |
| Q3 2021 | $2,621,000 | -18.1% | 100,000 | 0.0% | 0.54% | -14.6% |
| Q2 2021 | $3,201,000 | -54.5% | 100,000 | -50.0% | 0.64% | -67.8% |
| Q1 2021 | $7,042,000 | +9.8% | 200,000 | 0.0% | 1.98% | +102.3% |
| Q4 2020 | $6,414,000 | -65.9% | 200,000 | -60.0% | 0.98% | -71.2% |
| Q3 2020 | $18,810,000 | -15.9% | 500,000 | 0.0% | 3.40% | +56.5% |
| Q2 2020 | $22,375,000 | -49.5% | 500,000 | -61.5% | 2.18% | -65.1% |
| Q1 2020 | $44,343,000 | -12.5% | 1,300,000 | 0.0% | 6.23% | +2.8% |
| Q4 2019 | $50,700,000 | – | 1,300,000 | – | 6.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |